For example, SK1-I and PF-543, two potent SphK1 inhibitors, suppress the growth of glioblastoma (Kapitonov, 2010) and colorectal cancer cells (Ju et al., 2016) in xerograph mouse model, respectively. Here, SPHK1 is linked to colorectal cancer.